Laboratory Abnormalities in CKD-MBD: Markers, Predictors, or Mediators of Disease?

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Laboratory Abnormalities in CKD-MBD: Markers, Predictors, or Mediators of Disease?

This review summarizes the complex pathophysiology of CKD-MBD and outlines which laboratory abnormalities represent biomarkers of disease severity, which laboratory abnormalities are predictors of cardiovascular disease, and which laboratory abnormalities should be considered (direct) uremic toxins exerting organ damage. This information may help to streamline current and future therapeutic efforts.

Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Meiji Pharma
Faes Farma